CG Oncology is a leader in oncolytic immunotherapy, dedicated to advancing innovative, bladder-preserving treatments for patients with bladder cancer. The company focuses on the development of CG0070, striving to improve therapeutic outcomes and enhance the quality of life for those affected by this challenging disease.
Competitors of CG Oncology are Iovance Biotherapeutics, Apeiron Biologics, ImmunoGen, Rexahn Pharmaceuticals, Novartis.
What does CG Oncology do?
CG Oncology is a leader in oncolytic immunotherapy, dedicated to advancing innovative, bladder-preserving treatments for patients with bladder cancer. The company focuses on the development of CG0070, striving to improve therapeutic outcomes and enhance the quality of life for those affected by this challenging disease.